Sökning: "drug policy"
Visar resultat 21 - 25 av 71 avhandlingar innehållade orden drug policy.
21. Health financing systems and drug use in rural China
Sammanfattning : This thesis aims to study the association between health-care financing systems and health-care consumers' drug use and health providers' prescribing in six Chinese counties. In a cross-sectional study, a multistage sampling procedure was used to select provinces, counties, townships and villages. LÄS MER
22. Plasmodium falciparum drug transporter genes in emerging malaria multidrug resistance
Sammanfattning : Malaria is caused by an intracellular protozoan parasite of the genus Plasmodium. The use of chemotherapy, the foremost tool available for the control of the disease, has been challenged in the last decades by the development and spread of drug resistance among malaria parasites. LÄS MER
23. Drugs and the Convention on the Rights of the Child : Fragmentation, Contention and Structural Bias
Sammanfattning : Responding to the harms caused by drug use and the drug trade is one of the most pressing and interdisciplinary challenges of our time, within which the protection of children has become central. But there has been relatively little academic attention to the international legal dimensions of drug policy, despite the existence of a dedicated international legal framework on the issue and a range of other treaties that include drugs in some way. LÄS MER
24. Unequal drug treatment : age and educational differences among older adults
Sammanfattning : The overall aim of this thesis is to investigate whether drug treatment is unequally distributed among older adults on the basis of age and socioeconomic position. All studies in this thesis are based on nationwide register data from the Swedish Prescribed Drug Register (SPDR) record-linked to other registers in Sweden. LÄS MER
25. When Innovation Is Not Enough
Sammanfattning : Innovation is not always enough. In the beginning of the 2000s established pharmaceutical firms had developed several drugs, yet these new products were far too few. Patents of many blockbuster drugs were to soon expire and substantial profit would then be lost. LÄS MER